Episode Description
Listen to the episode on a streaming platform by clicking one of the links below:
CMS walked back its initial proposal for a flat MA rate increase and instead finalized a 2.48% payment bump.
The increase between the initial and final proposal follows a familiar pattern and highlights the strength of the payer lobby. But the reprieve might only be temporary if CMS goes forward next year with a proposed update to their risk adjustment model.
Reduced supplemental benefits have slowed the growth of MA relative to traditional Medicare, but the Trump administration is exploring ways to continue increasing its share, including automatic enrollment.
Changes to the star rating system will boost payments to plans that succeed on core clinical quality metrics, but the removal of metrics related to appeal timeliness and outcomes could let payers get away with aggressive prior authorization tactics.
A new study in JAMA finds that AI scribes reduce clinicians’ EHR times, but a claim that they also increase the volume of visits deserves careful scrutiny.
Reducing EHR time can also help providers avoid workforce burnout and boost retention, which might not be captured in existing measures of AI scribe ROI.
Anthropic has developed a new AI model called Claude Mythos with capabilities that could significantly enhance cyberattacks. The company is withholding it from public release over safety concerns.
Anthropic is working with major tech companies like Amazon, Apple, Google, and Microsoft to harden their systems with the help of the unreleased model. The company estimates that rival firms could develop models with similar capabilities in as little as 6 months.
The fragmented and custom-built software that health systems rely on could be particularly vulnerable to AI-assisted cyberattacks, and health systems could find themselves paying large sums to security vendors to reduce the risk of devastating outages.
At a recent public meeting, MedPAC presented study findings that the association between MA penetration and all-payer margins was consistently near zero across multiple sensitivity analyses.
Without more granular MA-specific data, the analysis may not isolate MA's true effect on health system margins—but that won't stop it from being held up as proof that MA pays enough.
Health systems could push federal policymakers to make better data available, following the example of states like California and Oregon.

About Our Host
Anika Rasheed
Anika is a Senior Analyst on the Strategy Catalyst team.